Article Versions Notes

Yarlagadda L, Gundarlapalli S, Parikh R, Landes RD, Kottarathara M, Ogunsesan Y, Hoque S, Mitma AA, Bailey C, Hill KM, et al. Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma. Cancers. 2021; 13(16):4019. https://doi.org/10.3390/cancers13164019

Yarlagadda, Lakshmi, Sravani Gundarlapalli, Richa Parikh, Reid D. Landes, Mathew Kottarathara, Yetunde Ogunsesan, Shadiqul Hoque, Angel A. Mitma, Clyde Bailey, Kerri M. Hill, and et al. 2021. "Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma" Cancers 13, no. 16: 4019. https://doi.org/10.3390/cancers13164019

Yarlagadda, L., Gundarlapalli, S., Parikh, R., Landes, R. D., Kottarathara, M., Ogunsesan, Y., Hoque, S., Mitma, A. A., Bailey, C., Hill, K. M., Thanendrarajan, S., Graziutti, M., Mohan, M., Zangari, M., van Rhee, F., Tricot, G., & Schinke, C. (2021). Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma. Cancers, 13(16), 4019. https://doi.org/10.3390/cancers13164019